Biocept Stock News

Biocept Inc (NASDAQ:BIOC) (FRA:B003) revealed to investors that it has received more than 420,000 samples for coronavirus testing since launching the service in June 2020.   The samples are processe

Biocept Inc (NASDAQ:BIOC) (FRA:B003) revealed to investors that it has received more than 420,000 samples for coronavirus testing since launching the service in June 2020.   The samples are processe

SAN DIEGO--(BUSINESS WIRE)--Biocept received more than 420,000 samples for COVID-19 testing since launching service in June 2020.

SAN DIEGO--(BUSINESS WIRE)--Biocept and CLEARED4 to develop new system for tracking and managing COVID-19 testing for campuses and other facilities returning to full capacity.

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purc

Biocept Inc (NASDAQ:BIOC) (FRA:B003) started 2021 on a high with a profitable first quarter on revenue of $17.8 million, driven primarily by its coronavirus (COVID-19) tests.  For the period ended M

Biocept, Inc. (BIOC) CEO Michael Nall on Q1 2021 Results - Earnings Call Transcript

Biocept Inc (NASDAQ:BIOC) has said it is partnering with the Foundation for California Community Colleges to make coronavirus (COVID-19) testing available for the state‘s 116 community colleges and

SAN DIEGO--(BUSINESS WIRE)--Biocept to provide COVID-19 testing to California community colleges and their more than 2.1 million students through FCCC partnership.

Biocept Inc (NASDAQ:BIOC) (FRA:B003) announced the full commercial launch of CNSide, the company's cerebrospinal fluid (CSF) assay designed to better detect and manage the treatment of metastatic ca

SAN DIEGO--(BUSINESS WIRE)-- #cancer--Biocept announces full launch of CNSide, its CSF assay designed to improve the management of metastatic cancers involving the central nervous system.

Biocept Inc (NASDAQ:BIOC) (FRA:B003) reports that since the company began offering SARS-CoV-2 testing services in June 2020, it has now received more than 350,000 samples.   These test samples are p

SAN DIEGO--(BUSINESS WIRE)---- $BIOC #Biocept--Biocept Provides Update on COVID-19 Testing with More than 350,000 Samples Received to Date

Biocept has been hard at work processing thousands of COVID-19 tests per week. As a result, the company reported its first profitable quarter and record full-year revenues.

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC) will host a webinar featuring leading neuro-oncologists to discuss the use of the Company's proprietary cerebrospinal fluid (CSF) assay for dia